Shunmugavelu, M and Shah, T and kumar, G V and Sudagani, J and Arivazhahan, A and Khader, J and Mohan, V (2019) Myths and Facts About Glimepiride. Journal of the Association of Physicians, 67 . p. 24.
Glimepiride is either used as monotherapy or in combination with metformin or insulin for effective control of hyperglycemia in people with type 2 diabetes mellitus. In spite of its effective glucose-lowering potential, similar to other sulfonylureas, glimepiride has been associated with several myths like cardiovascular risk, hypoglycemic effects, weight gain, beta-cell failure, risk in special populations of diabetic patients, and effects of metabolites. Here, we will discuss the myths and facts associated with glimepiride and its safety and concern issues
|Uncontrolled Keywords:||Type 2 Diabetes|
|Divisions:||Department of Diabetology|
|Deposited By:||surendar radha|
|Deposited On:||05 Feb 2020 14:18|
|Last Modified:||05 Feb 2020 14:18|
Repository Staff Only: item control page